Latest Commercialization News

Pure Foods Tasmania has secured a $400,000 investment from entrepreneurs Jon Kontopos and Matthew Abrahams as part of a broader $750,000 capital raising effort, reinforcing confidence in the company’s turnaround plan ahead of its upcoming shareholder vote.

Neuren Pharmaceuticals reported a robust half-year with an 88% increase in net profit, driven by rising royalties from DAYBUE™ sales and progress in its NNZ-2591 clinical program. The company also completed a $39.6 million share buy-back, underscoring confidence in its growth trajectory.

Metrics Real Estate Multi-Strategy Fund has released its inaugural annual report, revealing a strong start with $41.9 million profit before tax and distributions of 8.21 cents per unit following a $302.8 million IPO. The Fund’s diversified commercial real estate portfolio spans senior loans, mezzanine debt, and equity investments across Australia and New Zealand.

WiseTech Global posted robust FY25 results with 14% revenue growth and a 53% EBITDA margin excluding acquisition costs, while finalising the strategic e2open acquisition to broaden its global logistics software footprint.

Metrics Income Opportunities Trust reported a 6.6% increase in profit for FY25, achieving an 8.8% net return and maintaining strong portfolio diversification in private credit assets.

WiseTech Global reported robust FY25 results with a 14% revenue increase and a 53% EBITDA margin, boosted by strong CargoWise growth and the strategic acquisition of e2open. The company is poised to accelerate growth through AI innovations and a new commercial model.

BCAL Diagnostics has partnered with Sonic Healthcare Australia to broaden access to its innovative blood-based breast cancer test, BREASTEST plus™, across Sydney. This move formalizes a commercial rollout following successful trials and aims to improve early detection for women with dense breast tissue.

Proteomics International Laboratories reported a 26% increase in losses for FY2025, driven by higher operational costs as it advances its Promarker® diagnostic pipeline. Despite an 8% rise in revenue from ordinary activities, total income slipped 2%, underscoring ongoing commercialisation challenges.

NH3 Clean Energy has launched the FEED phase for its WAH2 clean ammonia project, advancing environmental approvals and commercial negotiations with potential strategic partners.

EML Payments reported a 9% revenue increase and 13% rise in underlying EBITDA for FY25, driven by strategic partnerships and operational transformation. The company sets a steady growth outlook for FY26 despite expected interest revenue headwinds.

Tabcorp Holdings Limited reported a robust FY25 with revenue climbing 11.8% and EBIT nearly doubling, driven by Victorian wagering licence reforms and disciplined cost management. The company’s strategic evolution and operational execution set the stage for modest growth in FY26.

Tabcorp Holdings Limited has reported a significant financial turnaround for FY25, driven by the new Victorian Wagering and Betting Licence and strategic operational improvements. The company posted $2.6 billion in revenue and a net profit after tax of $36.6 million, reversing last year's substantial loss.